AstraZeneca eyes over two billion doses of potential COVID-19 vaccine after deals
Published
Britain's AstraZeneca said on Thursday it would now be able to supply more than two billion doses of its potential coronavirus vaccine, thanks to a string of manufacturing deals including one with CEPI.
Full Article